Applied Therapeutics, Inc. — Director's Dealing 2024

Dec 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2024-12-19

Reporting Person: JOHNSON JOHN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-19	Common Stock	A	500000	—	Acquired	500000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-19	Stock Option (Right to Buy)	$1.02	A	1000000	Acquired	2034-12-19	Common Stock (1000000)	Direct

Footnotes

F1: Consists of compensatory Restricted Stock Units ("RSUs") granted outside of Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan pursuant to the inducement grant exception under Nasdaq Rule 5635(c). Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs will vest in equal annual installments on each of the first two anniversaries of the grant date, subject to the Reporting Person continuing to provide services through each such date.

F2: Consists of compensatory Options granted outside of Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan pursuant to the inducement grant exception under Nasdaq Rule 5635(c). The shares subject to the Option will vest in equal annual installments on each of the first two anniversaries of the grant date, subject to the Reporting Person continuing to provide services through each such date.